{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:07:15Z","timestamp":1768352835393,"version":"3.49.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173416"],"award-info":[{"award-number":["82173416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222059"],"award-info":[{"award-number":["82222059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930087"],"award-info":[{"award-number":["81930087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330096"],"award-info":[{"award-number":["82330096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2509005"],"award-info":[{"award-number":["2023YFC2509005"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clim.2024.110171","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:39:57Z","timestamp":1709933997000},"page":"110171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["From mice to men: An assessment of preclinical model systems for the study of vitiligo"],"prefix":"10.1016","volume":"262","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2024.110171_bb0005","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0015","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: a systematic review and meta-analysis of observational studies","volume":"177","author":"Lai","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/jdv.14739","article-title":"The prevalence and odds of depression in patients with vitiligo: a meta-analysis","volume":"32","author":"Wang","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2024.110171_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/CCID.S76088","article-title":"The psychosocial impact of acne, vitiligo, and psoriasis: a review","volume":"9","author":"Nguyen","year":"2016","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40257-016-0172-x","article-title":"Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional controlled study","volume":"17","author":"Salman","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0035","article-title":"Clinical features, Immunopathogenesis, and therapeutic strategies in vitiligo","author":"Wang","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1515\/hsz-2013-0279","article-title":"The top skin-associated genes: a comparative analysis of human and mouse skin transcriptomes","volume":"395","author":"Gerber","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.clim.2024.110171_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.12.009","article-title":"Skin wound healing in humans and mice: challenges in translational research","volume":"90","author":"Zomer","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0050","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110171_bb0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12524353","article-title":"A mouse model for vitiligo","volume":"87","author":"Lerner","year":"1986","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(93)90429-T","article-title":"Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein","volume":"74","author":"Hodgkinson","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.110171_bb0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/genetics\/155.1.291","article-title":"Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus","volume":"155","author":"Hallsson","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.clim.2024.110171_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2005.03.021","article-title":"Melanocyte stem cell maintenance and hair graying","volume":"121","author":"Steingr\u00edmsson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.110171_bb0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/cr.2008.303","article-title":"Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf?","volume":"18","author":"Hou","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.clim.2024.110171_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003648","article-title":"A direct link between MITF, innate immunity, and hair graying","volume":"16","author":"Harris","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.clim.2024.110171_bb0090","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/CCID.S319061","article-title":"Identification of the role of Wnt\/\u03b2-catenin pathway through integrated analyses and in vivo experiments in vitiligo","volume":"14","author":"Zhao","year":"2021","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0625.1995.tb00217.x","article-title":"Low ICAM-1 expression in the epidermis of depigmenting C57BL\/6J-mivit\/mivit mice: a possible cause of muted contact sensitization","volume":"4","author":"Nordlund","year":"1995","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0100","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.140.10.3438","article-title":"Immune studies in the depigmenting C57BL\/Ler-vit\/vit mice. An apparent isolated loss of contact hypersensitivity","volume":"140","author":"Amornsiripanitch","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0105","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archderm.1987.01660320064013","article-title":"Langerhans\u2019 cells in hair follicles of the depigmenting C57Bl\/Ler-vit.Vit mouse. A model for human vitiligo","volume":"123","author":"Palkowski","year":"1987","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0110","first-page":"1511","article-title":"Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse","volume":"138","author":"Boissy","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2024.110171_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng0692-226","article-title":"Light is a dominant mouse mutation resulting in premature cell death","volume":"1","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2024.110171_bb0120","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1073\/pnas.87.12.4809","article-title":"Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity","volume":"87","author":"Halaban","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.110171_bb0125","doi-asserted-by":"crossref","first-page":"176s","DOI":"10.1038\/jid.1993.73","article-title":"White mutants in mice shedding light on humans","volume":"100","author":"Halaban","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.clim.2024.110171_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-induced vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.clim.2024.110171_bb0140","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1002\/anie.200601255","article-title":"The first crystal structure of tyrosinase: all questions answered?","volume":"45","author":"Decker","year":"2006","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.clim.2024.110171_bb0145","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/icb\/icab078","article-title":"Melanosome biogenesis in the pigmentation of mammalian skin","volume":"61","author":"Le","year":"2021","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.clim.2024.110171_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.12449","article-title":"Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo","volume":"23","author":"Webb","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0155","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/bjd.13642","article-title":"Topical monobenzyl ether of hydroquinone is an effective and safe treatment for depigmentation of extensive vitiligo in the medium term: a retrospective cohort study of 53 cases","volume":"172","author":"Tan","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/exd.12184","article-title":"A mouse model of vitiligo induced by monobenzone","volume":"22","author":"Zhu","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0165","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.immuni.2016.05.008","article-title":"Inflammasome-dependent induction of adaptive NK cell memory","volume":"44","author":"van den Boorn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110171_bb0170","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0625.2010.01200.x","article-title":"The haptenation theory of vitiligo and melanoma rejection: a close-up","volume":"20","author":"Westerhof","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0180","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/ptr.5161","article-title":"The effects of galangin on a mouse model of vitiligo induced by hydroquinone","volume":"28","author":"Huo","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.clim.2024.110171_bb0185","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ptr.5794","article-title":"The effect of Butin on the vitiligo mouse model induced by hydroquinone","volume":"31","author":"Huo","year":"2017","journal-title":"Phytother. Res."},{"key":"10.1016\/j.clim.2024.110171_bb0190","article-title":"Apigenin protects melanocytes and improve tyrosinase activity in a hydroquinone induced vitiligo mouse model targeting P38 MAP kinase signaling: histopathology and immunohistochemistry analysis","author":"Chauhan","year":"2023","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.clim.2024.110171_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2015.02.001","article-title":"Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma","volume":"77","author":"Tokura","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdermsci.2015.10.011","article-title":"Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin","volume":"81","author":"Abe","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.15878","article-title":"Rhododendrol-induced leukoderma update II: pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo","volume":"48","author":"Inoue","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jdermsci.2019.06.009","article-title":"Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma","volume":"95","author":"Arase","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0215","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/1346-8138.14879","article-title":"Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo","volume":"46","author":"Hayashi","year":"2019","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0220","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/0008-5472.CAN-03-3227","article-title":"Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin","volume":"64","author":"Lane","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2024.110171_bb0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cei.12146","article-title":"Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo","volume":"174","author":"You","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0230","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.63","article-title":"Mouse model for human vitiligo","volume":"124","author":"Riding","year":"2019","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101349","article-title":"Epigenetic regulation of melanogenesis","volume":"69","author":"Zhou","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.clim.2024.110171_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.0022-202x.2001.00006.x","article-title":"Review: melanocyte migration and survival controlled by SCF\/c-kit expression","volume":"6","author":"Yoshida","year":"2001","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.clim.2024.110171_bb0250","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1101\/gad.300665.117","article-title":"Identifying the niche controlling melanocyte differentiation","volume":"31","author":"Zocco","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.clim.2024.110171_bb0255","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1242\/dev.125.15.2915","article-title":"Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors","volume":"125","author":"Kunisada","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.clim.2024.110171_bb0260","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7150\/thno.39066","article-title":"Stem cell factor-inducible MITF-M expression in therapeutics for acquired skin hyperpigmentation","volume":"10","author":"Yun","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.clim.2024.110171_bb0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2017.06.018","article-title":"Precise role of dermal fibroblasts on melanocyte pigmentation","volume":"88","author":"Wang","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0270","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.1538","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M","volume":"202","author":"Kitamura","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.clim.2024.110171_bb0275","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.jid.5701247","article-title":"Epidermal stem cell factor augments the inflammatory response in irritant and allergic contact dermatitis","volume":"128","author":"Carter","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0280","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/pcmr.12935","article-title":"Type I interferon signaling limits viral vector priming of CD8(+) T cells during initiation of vitiligo and melanoma immunotherapy","volume":"34","author":"Riding","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.clim.2024.110171_bb0285","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.jid.2022.06.007","article-title":"A keratinocyte-tethered biologic enables location-precise treatment in mouse vitiligo","volume":"142","author":"Hsueh","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0290","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.clim.2024.110171_bb0295","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20041130","article-title":"Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells","volume":"200","author":"Turk","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0300","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-07-1264","article-title":"Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2024.110171_bb0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","article-title":"A mouse model of vitiligo based on endogenous auto-reactive CD8+T cell targeting skin melanocyte","volume":"11","author":"Chen","year":"2022","journal-title":"Cell Regen"},{"key":"10.1016\/j.clim.2024.110171_bb0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1082305","article-title":"Requirement for CD4 T cell help in generating functional CD8 T cell memory","volume":"300","author":"Shedlock","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.clim.2024.110171_bb0315","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection","volume":"5","author":"Sun","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.1830170706","article-title":"Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site","volume":"17","author":"Moreau","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2024.110171_bb0330","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-T(reg)-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.clim.2024.110171_bb0335","first-page":"1636","article-title":"In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties","volume":"40","author":"Poste","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2024.110171_bb0340","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0350","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2014.57.4756","article-title":"Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis","volume":"33","author":"Teulings","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2024.110171_bb0355","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.onc.1202077","article-title":"Transgenic mouse model for skin malignant melanoma","volume":"17","author":"Kato","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2024.110171_bb0360","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/0008-5472.CAN-03-2828","article-title":"Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells","volume":"64","author":"Lengagne","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2024.110171_bb0365","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.1073\/pnas.1300314110","article-title":"Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells","volume":"110","author":"Pommier","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.110171_bb0370","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4161\/onci.20068","article-title":"The split nature of tumor-infiltrating leukocytes: implications for cancer surveillance and immunotherapy","volume":"1","author":"Lan\u00e7a","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clim.2024.110171_bb0375","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20100269","article-title":"Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy","volume":"208","author":"Ma","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0380","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1172\/JCI36022","article-title":"NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo","volume":"119","author":"Lakshmikanth","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110171_bb0385","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0390","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The principles of engineering immune cells to treat Cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.110171_bb0395","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","article-title":"Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy","volume":"576","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.clim.2024.110171_bb0400","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI121491","article-title":"T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy","volume":"129","author":"Yamamoto","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2024.110171_bb0405","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cell.2018.10.028","article-title":"NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines","volume":"175","author":"van Montfoort","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clim.2024.110171_bb0410","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1084\/jem.20181218","article-title":"Host conditioning with IL-1\u03b2 improves the antitumor function of adoptively transferred T cells","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00262-018-02294-5","article-title":"The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice","volume":"68","author":"Sultan","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2024.110171_bb0420","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1073\/pnas.0307298101","article-title":"IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells","volume":"101","author":"Klebanoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2024.110171_bb0425","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.179.2.993","article-title":"Deletional self-tolerance to a melanocyte\/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes","volume":"179","author":"Nichols","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0430","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jid.2019.08.435","article-title":"Antibiotics drive microbial imbalance and vitiligo development in mice","volume":"140","author":"Dellacecca","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0435","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0440","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.1103271","article-title":"A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice","volume":"189","author":"Mehrotra","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0445","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.581433","article-title":"Antigen specificity enhances disease control by Tregs in vitiligo","volume":"11","author":"Mukhatayev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0455","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to activate Treg migration and suppress depigmentation in vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0460","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1158\/0008-5472.CAN-15-1798","article-title":"Lack of p53 augments antitumor functions in Cytolytic T cells","volume":"76","author":"Banerjee","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2024.110171_bb0465","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/pcmr.12284","article-title":"Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation","volume":"27","author":"Eby","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.clim.2024.110171_bb0470","first-page":"81","article-title":"Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes","volume":"24","author":"Rozengurt","year":"1995","journal-title":"Cancer Surv."},{"key":"10.1016\/j.clim.2024.110171_bb0475","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1471-4159.2009.06023.x","article-title":"Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide","volume":"109","author":"Rosmaninho-Salgado","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.clim.2024.110171_bb0480","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2133.1994.tb08486.x","article-title":"Neuropeptide and neuronal marker studies in vitiligo","volume":"131","author":"Al\u2019Abadie","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0485","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1076\/1381345520000710831ZFT262","article-title":"Vitiligo-related neuropeptides in nerve fibers of the skin","volume":"108","author":"Lazarova","year":"2000","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.clim.2024.110171_bb0490","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0923-1811(01)00134-7","article-title":"Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo","volume":"27","author":"Tu","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0495","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/BF02505276","article-title":"The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study","volume":"288","author":"Liu","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2024.110171_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","volume":"9","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110171_bb0505","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/exd.14406","article-title":"A novel mouse model to evaluate neuropeptide Y-mediated melanocyte pathology","volume":"30","author":"Anderson","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102932","article-title":"Autoimmunity in vitiligo: therapeutic implications and opportunities","volume":"21","author":"Khaitan","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2024.110171_bb0515","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2003.05024.x","article-title":"Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo","volume":"148","author":"Gauthier","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0520","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/jid.2015.25","article-title":"Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo","volume":"135","author":"Wagner","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0525","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1074\/jbc.M511367200","article-title":"Regulation of integrin activity by MIA","volume":"281","author":"Bauer","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt 10","key":"10.1016\/j.clim.2024.110171_bb0530","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1242\/jcs.107.10.2739","article-title":"Role of integrins in melanocyte attachment and dendricity","volume":"107","author":"Hara","year":"1994","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0535","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fmed.2020.00430","article-title":"Melanoma inhibitory activity (MIA) is able to induce vitiligo-like depigmentation in an in vivo mouse model by direct injection in the tail","volume":"7","author":"Bordignon","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.clim.2024.110171_bb0540","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bjd.16049","article-title":"The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis","volume":"178","author":"Osinubi","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0545","first-page":"255","article-title":"Vitiligo disease triggers: psychological stressors preceding the onset of disease","volume":"95","author":"Silverberg","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.clim.2024.110171_bb0550","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jaad.2021.02.083","article-title":"Factors associated with perceived stress in patients with vitiligo in the ComPaRe e-cohort","volume":"86","author":"Condamina","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227909","article-title":"The relationship between stress and vitiligo: evaluating perceived stress and electronic medical record data","volume":"15","author":"Henning","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2024.110171_bb0560","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1468-3083.2006.02106.x","article-title":"Stress in patients with alopecia areata and vitiligo","volume":"21","author":"Manolache","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2024.110171_bb0565","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/exd.13380","article-title":"Effects of two chronic stresses on mental state and hair follicle melanogenesis in mice","volume":"26","author":"Liao","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0570","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1096\/fj.201701242RR","article-title":"IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo","volume":"32","author":"Zhou","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.clim.2024.110171_bb0575","article-title":"Optimization of Monobenzone-induced vitiligo mouse model by the addition of chronic stress","volume":"24","author":"Dong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2024.110171_bb0580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molimm.2023.07.007","article-title":"Restraint stress promotes monobenzone-induced depigmentation in mice via the activation of glucocorticoid receptor\/macrophage migration inhibitory factor signaling pathway","volume":"161","author":"Tang","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0585","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"88","author":"Ezzedine","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0590","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaci.2023.09.021","article-title":"Improvements in immune\/melanocyte biomarkers with JAK3\/TEC family kinase inhibitor ritlecitinib in vitiligo","volume":"153","author":"Guttman-Yassky","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2024.110171_bb0595","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2024.110171_bb0600","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jid.2020.04.027","article-title":"Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells","volume":"141","author":"Azzolino","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2024.110171_bb0610","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1038\/s41467-023-42714-4","article-title":"Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2024.110171_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122387","article-title":"The skin delivery of tofacitinib citrate using transethosomes and hybridized ethosomes\/nanostructured lipid carriers for vitiligo therapy: Dermatopharmacokinetics and in vivo assays","volume":"629","author":"Hesham","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.clim.2024.110171_bb0620","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12967-023-04293-2","article-title":"Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo","volume":"21","author":"Chang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2024.110171_bb0625","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661624000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T06:55:46Z","timestamp":1720594546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661624000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":125,"alternative-id":["S1521661624000627"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2024.110171","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From mice to men: An assessment of preclinical model systems for the study of vitiligo","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2024.110171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110171"}}